Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Healthcare & PharmaceuticalCompany Update

Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues

February 5, 2026 8:30 AM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The...

Read more
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging

February 5, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing small-molecule therapeutics targeting fundamental biological mechanisms implicated in cancer, aging, and degenerative disease, today announced new cellular study results demonstrating that Telomir-1, in the form of Telomir-Zn, induces a rapid and coordinated intracellular redistribution of zinc and iron. These findings...

Read more
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit
Healthcare & PharmaceuticalConferences

Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit

February 5, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), wholly owned subsidiary, Buzz Bomb Caffeine Company, a marketer of a proprietary sublingual caffeine supplement today announced its participation at The Sports & Active Nutrition Summit USA, scheduled for February 18-20 in San Diego, CA. Aspire will feature its flagship caffeine product, BUZZ BOMB™, at the event. The Sports & Active Nutrition Summit USA is a premier...

Read more
Zomedica Announces
Healthcare & PharmaceuticalCompany Update

Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline

February 5, 2026 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative diagnostic and therapeutic devices for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, February 27, 2026 at 4:00 p.m. Eastern Time. The February program, titled "Inside Innovation: Advancing Animal Health Through Research & Development," will...

Read more
BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Healthcare & PharmaceuticalCompany Update

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery

February 5, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, today announced the signing of a non-binding letter of intent ("LOI") outlining a proposed transaction pursuant to which BioNxt would secure exclusive rights to advanced drug chaperone technology for oral dissolvable applications from a third-party biotechnology developer focused on...

Read more
Bio-Xin Cosmeceuticals Announces Expansion of Personalized Skincare Solutions Globally
Healthcare & PharmaceuticalCompany Update

Bio-Xin Cosmeceuticals Announces Expansion of Personalized Skincare Solutions Globally

February 5, 2026 3:00 AM

Bio-Xin Cosmeceuticals, led by Founder & CEO Muhammad Zahidul Hoque, is set to expand its personalized skincare solutions globally, revolutionizing the industry through science and empowerment. Revolutionizing Aesthetic Care with Personalized Solutions Bio-Xin Cosmeceuticals, a leading force in the global skincare and wellness industry, is taking a significant step forward in its mission to revolutionize the skincare experience. The company,...

Read more
MEDvidi Announces AI Clinical Assistant to Address the Shortage of Mental Health Professionals
Healthcare & PharmaceuticalCompany Update

MEDvidi Announces AI Clinical Assistant to Address the Shortage of Mental Health Professionals

February 5, 2026 2:55 AM

The mental health sector is poised for transformation. More than 32 million Americans face barriers to treatment, and the national shortage of mental health professionals is projected to exceed 20,000 by 2030. Today, with over 65% of clinicians' time being consumed by administrative work and routine follow-up visits, the current healthcare delivery model becomes unsustainable. MEDvidi's AI systems are built to change that. Instead of...

Read more
Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism
Healthcare & PharmaceuticalCompany Update

Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism

February 5, 2026 2:50 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), an advanced clinical-stage biotech developing novel radiopharmaceuticals, today announced publication of new Phase 2 clinical data in the Journal of Nuclear Medicine demonstrating the potential of [68Ga]Ga-Pentixafor PET/CT as a non-invasive imaging tool for subtyping primary aldosteronism (PA), the leading endocrine cause of hypertension. The investigator-initiated study, funded by an...

Read more
Spago Nanomedical Year-End Report January-December, 2025
Healthcare & PharmaceuticalEarnings

Spago Nanomedical Year-End Report January-December, 2025

February 5, 2026 2:20 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) OCTOBER - DECEMBER IN BRIEF Net sales for the quarter amounted to KSEK 4 (KSEK 617) The loss for the quarter amounted to KSEK -5,890 (KSEK -7,830) Operating expenses for the quarter amounted to KSEK -6,943 (KSEK -10,223) Earnings per share, before and after dilution, for the quarter amounted to SEK -0.01 (SEK -0. 02) JANUARY - DECEMBER IN BRIEF Net sales for the year amounted to KSEK 437 (KSEK 1,911)...

Read more
Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review
Healthcare & PharmaceuticalEarnings

Full Year and Q4 Report 2025: FDA Accepts Orviglance NDA for Review

February 5, 2026 1:50 AM

Ascelia Pharma AB (publ) (ticker:ACE)(STO:ACE) today published its Full Year and Q4 Report for 2025 (January - December), which is now available on the company's website: Financial Reports - ASCELIA KEY EVENTS IN Q4 2025 FDA accepts Orviglance® NDA for review aiming for a decision by 3 July 2026 as the PDUFA date Filing of a new patent application for Orviglance Management changes to support future growth Conversion of series C shares into...

Read more
RenuviaRX NAD+ Therapy: 2026 Consumer Guide Examines Telehealth NAD+ Program Pricing, Process and What to Expect
Healthcare & PharmaceuticalAdvertorial

RenuviaRX NAD+ Therapy: 2026 Consumer Guide Examines Telehealth NAD+ Program Pricing, Process and What to Expect

February 4, 2026 10:25 PM

Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you.This article is for informational purposes only and does not constitute medical advice. NAD+ therapy requires evaluation by a licensed healthcare provider. Always consult a qualified healthcare professional before starting any treatment. RenuviaRX NAD+ Therapy Review (2026): What It Is, How It Works,...

Read more
Life Imaging FLA Reviews the Biggest Questions in Preventive Screening for 2026
Healthcare & PharmaceuticalCompany Update

Life Imaging FLA Reviews the Biggest Questions in Preventive Screening for 2026

February 4, 2026 7:05 PM

Life Imaging FLA today announced a new 2026 initiative that will systematically review the biggest questions in preventive screening and early detection, with a focus on heart disease and cancer. The company, which provides preventive heart and full body screening for adults over 20, will use this internal review to strengthen how it educates the public, supports clinicians, and designs its own services. "Every year, we see how much difference...

Read more
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Healthcare & PharmaceuticalCompany Update

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus

February 4, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Alberta, British Columbia, Manitoba and Ontario. The Base Shelf Prospectus has been filed, but is not yet final, and the securities described therein may...

Read more
URLuminous Marks World Cancer Day By Advancing Awareness-First Breast Health With Luminous Pro Series And Companion App
Healthcare & PharmaceuticalCompany Update

URLuminous Marks World Cancer Day By Advancing Awareness-First Breast Health With Luminous Pro Series And Companion App

February 4, 2026 2:50 PM

In recognition of World Cancer Day, URLuminous is spotlighting its mission to transform breast health through awareness-first technology with the Luminous Pro Series and the Luminous Breast App - tools designed to help individuals and physicians build familiarity with breast health and encourage earlier medical follow-up when changes are detected. The Luminous Pro Series is currently used in various international markets and has received...

Read more
John H. Weston Jr. Launches a Personal Pledge to Reduce Preventable Behavioral Crises in Community Care
Healthcare & PharmaceuticalCompany Update

John H. Weston Jr. Launches a Personal Pledge to Reduce Preventable Behavioral Crises in Community Care

February 4, 2026 11:03 AM

John H. Weston Jr., operator and leader of Capitol City Residential Health Care, today announced the launch of a personal pledge focused on reducing preventable behavioral crises in community-based residential settings. The pledge formalizes a set of concrete behaviors Weston has committed to in response to rising acuity, staffing pressure, and avoidable emergency interventions across the sector. The pledge is grounded in operational realities...

Read more
Utah Medical Products, Inc. Announces Quarterly Dividend
Healthcare & PharmaceuticalDividends

Utah Medical Products, Inc. Announces Quarterly Dividend

February 4, 2026 10:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on April 3, 2026 to stockholders of record at the close of business on March 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year. Utah Medical Products, Inc., with particular interest in health care for women and their babies,...

Read more
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States
Healthcare & PharmaceuticalAwards

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States

February 4, 2026 9:45 AM

AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the...

Read more
Revecore Earns Sixth Consecutive Best in KLAS Award for Complex Claims Services
Healthcare & PharmaceuticalAwards

Revecore Earns Sixth Consecutive Best in KLAS Award for Complex Claims Services

February 4, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced it has earned its sixth consecutive Best in KLAS award for Complex Claims Services in the 2026 Best in KLAS: Software & Services Report. With this distinction, Revecore builds on the record it established in 2025 for the most consecutive Best in KLAS wins in the Complex Claims category. The Best in KLAS awards are based on...

Read more
CenExel Completes Metabolic Task Force Training Across Site Network
Healthcare & PharmaceuticalCompany Update

CenExel Completes Metabolic Task Force Training Across Site Network

February 4, 2026 9:00 AM

CenExel, a leading, wholly owned clinical research site network, recently completed its comprehensive Metabolic Task Force training, one of three Task Forces designed to advance a unified approach to patient-focused care. The training is a direct response to the highly evolving pace of metabolic research, such as GLP-1s, and the growing need to navigate the complexities of emerging metabolic clinical trials. Ensuring clinical sites are equipped...

Read more
EDGE Surgical to Showcase Rapid Growth and Global Expansion at AAOS 2026
Healthcare & PharmaceuticalConferences

EDGE Surgical to Showcase Rapid Growth and Global Expansion at AAOS 2026

February 4, 2026 9:00 AM

EDGE Surgical, Inc., the pioneering force behind the world's only electronic depth gauge for orthopedic surgery, is thrilled to announce its participation as an exhibitor at the 2026 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting, taking place from March 2-6 at the Morial Convention Center in New Orleans, Louisiana. EDGE will highlight accelerating commercial growth, expanding surgeon adoption, and continued progress toward global...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?